Natalizumab for Moderate-to-Severe Crohn's Disease.
Article Details
- CitationCopy to clipboard
Dryden GW
Natalizumab for Moderate-to-Severe Crohn's Disease.
Gastroenterol Hepatol (N Y). 2008 Apr;4(4):296.
- PubMed ID
- 21960916 [ View in PubMed]
- Abstract
Not Available
DrugBank Data that Cites this Article
- Drugs